JSS Selects OmniComm TrialMaster EDC

Article

OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research.

OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research. OmniComm’s TrialMaster platform will be used for the collection of data in numerous clinical trials across global investigative sites.

Read the full release here

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.